Change of Company Secretary
Released
Released
Announcement PDF
ASX Announcement
4 March 2024
Change of Company Secretary
Atomo Diagnostics Limited (ASX: AT1) (Atomo or the Company) wishes to advise in
accordance with ASX Listing Rule 3.16.1 that Ms Sally McDow of BoardRoom Pty Limited has
been appointed Company Secretary, with effect from 5 March 2024. For the purposes of ASX
Listing Rule 12.6, Ms Sally McDow will also be the primary person responsible for
communications between the Company and the ASX.
Ms Maria Clemente of BoardRoom Pty Limited has notified the Board of her resignation as
Company Secretary with effect from 5 March 2024. Atomo thanks Ms Clemente for her
support of the Board during her time with the Company.
For more information:
John Kelly
MD & CEO, Atomo Diagnostics Limited
john.kelly@atomodiagnostics.com
+61 401 922 279
This announcement was authorised by the Board of Atomo Diagnostics Limited.
About Atomo
Atomo is an Australian headquartered medical device company supplying unique, integrated rapid
diagnostic test (RDT) devices to the global diagnostic market.
Atomo’s unique patented devices simplify testing procedures, enhance usability and improve reliability
across rapid point-of-care (POC) and at-home testing applications. The Company has successfully
commercialised a number of products across international markets and has supply agreements in place
for testing applications targeting infectious diseases including COVID-19, HIV, viral vs bacterial
differentiation and female health.
See more at www.atomodiagnostics.com
Atomo Diagnostics Limited
ACN 142 925 684
Level 1, 3-5 George St Leichhardt NSW 2040
Share your feedback
Discover